| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥84.8B | ¥89.8B | -5.7% |
| Operating Income | ¥-2.3B | ¥-0.1B | -1433.3% |
| Ordinary Income | ¥-1.6B | ¥0.9B | -272.3% |
| Net Income | ¥-26.7B | ¥3.9B | -792.8% |
| ROE | -33.6% | 3.7% | - |
The Character Printing Recording Media and Office Consumables Related segment generated revenue of 80.4B yen (-6.7% YoY) with segment profit of 17.0B yen (-16.8% YoY), representing 94.9% of total revenue and serving as the core business. Segment profit margin declined to 21.1% from 23.7% YoY, indicating margin compression from pricing pressure and unfavorable product mix. The segment recorded impairment losses of 24.8B yen during the period, concentrated in this division's asset base. The Plastic Molding segment achieved revenue of 4.4B yen (+18.6% YoY) with segment profit of 0.96B yen (+49.1% YoY), delivering a superior profit margin of 21.9% versus 14.8% in the prior year. Despite smaller scale at 5.1% of total revenue, this segment demonstrated stronger growth momentum and margin expansion, suggesting potential for increased strategic focus. The core printing media business faces structural challenges requiring price realization and cost efficiency improvements, while the plastic molding operation shows resilience with both volume growth and profitability enhancement.
[Profitability] ROE -33.6% (severely negative due to net loss), operating margin -2.7% (deteriorated from -0.1% YoY). Gross margin 21.2% contracted 2.2 percentage points from 23.4% YoY. SG&A ratio 23.9% increased 0.4 percentage points despite absolute cost reduction, indicating insufficient operating leverage. Net profit margin -31.5% reflects both operational challenges and non-recurring impairment impact. [Cash Quality] Cash and deposits 25.4B yen covers short-term debt with substantial cushion at current ratio of 268.0% and quick ratio of 240.1%. Operating CF to net income ratio of -0.04x signals earnings quality concerns, as cash generation severely lagged reported loss. Cash conversion efficiency measured by OCF/EBITDA of 0.23x indicates only 23% of EBITDA converted to operating cash. [Investment Efficiency] Asset turnover 0.61x remained stable. Total asset base contracted to 138.7B yen from 164.4B yen (-15.6%), primarily through property, plant and equipment reduction of 17.3B yen (-27.6%) and intangible asset decrease of 4.4B yen (-91.3%), both linked to impairment charges. Working capital efficiency deteriorated with DSO of 84 days and DIO of 125 days, producing cash conversion cycle of 191 days. [Financial Health] Equity ratio 57.4% (down from 64.3% YoY due to loss absorption), current ratio 268.0%, debt-to-equity 0.24x remains conservative. Long-term loans increased 4.1B yen to 19.2B yen (+27.2%), raising Debt/EBITDA to 4.39x. Interest coverage turned negative at -7.1x due to operating loss, though absolute interest expense remained modest at 0.3B yen.
Operating CF of 1.0B yen represents 0.04x of net income (absolute basis), confirming severe cash-backed earnings deterioration relative to reported loss. The company generated only 1.5B yen in operating CF before working capital changes, reduced by working capital consumption including inventory increase of 3.4B yen and accounts payable decrease of 4.9B yen, partially offset by receivables collection improvement contributing 7.1B yen inflow. Investing CF of -5.3B yen was primarily driven by CapEx of 5.6B yen, representing 0.84x of depreciation (6.7B yen), suggesting capital investment discipline with maintenance-level spending below asset consumption. Financing CF of 0.6B yen reflected minimal activity with negligible share repurchases. FCF of -4.3B yen indicates the company consumed cash after capital expenditure, requiring balance sheet liquidity to fund operations. The 6.7B yen depreciation charge substantially exceeded operating CF generation, highlighting cash conversion challenges. Cash and deposits decreased from prior period levels despite positive operating CF, as working capital absorption and capital expenditure exceeded operational cash generation capacity.
Ordinary loss of -1.6B yen versus operating loss of -2.3B yen shows non-operating net contribution of approximately 0.7B yen, comprising primarily dividend income of 0.6B yen and FX gains of 0.3B yen against interest expense of 0.3B yen. Non-operating income represents 1.3% of revenue with stable dividend income and favorable currency effects providing modest support. However, the gap between ordinary loss and net loss exceeds 25B yen due to extraordinary items, with impairment losses of 24.8B yen representing 29.2% of revenue and constituting a material non-recurring charge. Operating CF of 1.0B yen severely underperformed relative to operating loss magnitude, as working capital deterioration absorbed 7.6B yen (inventory build of 3.4B yen and payables reduction of 4.9B yen). The OCF/EBITDA ratio of 0.23x indicates only 23% of EBITDA converted to cash, signaling accruals build-up and earnings quality concerns even adjusting for extraordinary items. The combination of negative operating margins, substantial non-cash impairment charges, and weak cash conversion indicates low recurring earnings quality requiring operational restructuring to restore sustainable profitability and cash generation.
Progress rate versus full-year guidance shows revenue achievement of 94.2% (84.8B yen actual vs 90.0B yen forecast), operating loss versus operating income forecast of 1.5B yen, ordinary loss versus ordinary income forecast of 1.2B yen, indicating substantial shortfall against initial expectations. The company maintained full-year guidance of revenue 90.0B yen (+6.2% YoY), operating income 1.5B yen (recovery to profitability), ordinary income 1.2B yen, and EPS forecast of 359.32 yen despite full-year results already reported, suggesting these figures represent preliminary outlook rather than achieved results requiring clarification. Actual FY2025 results fell significantly short of internal targets, with operating loss of -2.3B yen versus +1.5B yen forecast (-3.8B yen shortfall) and net loss of -26.7B yen versus implied profit, primarily due to unforecasted impairment charges of 24.8B yen. The revenue shortfall of 5.2B yen (-5.8%) indicates demand challenges exceeded management expectations, while the absence of revised guidance suggests potential reporting timing interpretation issues or preliminary next-period framework presentation.
Annual dividend of 78 yen per share maintained despite net loss of -26.7B yen. The reported payout ratio of 30.0% appears calculated on a normalized or target basis rather than actual earnings, as dividend payment of 1.4B yen against net loss produces mathematically negative conventional payout ratio. Dividend payment consumes -5.2% of net income (negative earnings basis) or represents total shareholder payout from capital reserves given the loss position. Total return ratio considering dividends of 1.4B yen and negligible share buybacks against negative net income indicates dividends funded entirely from retained earnings or capital surplus rather than current period earnings. The dividend note specifies that the FY2025 year-end dividend is entirely sourced from capital surplus rather than retained earnings, confirming non-earnings-based distribution. FCF of -4.3B yen indicates dividend payment not supported by free cash flow, requiring balance sheet liquidity drawdown. The dividend policy for FY2026 remains undetermined per management disclosure, suggesting future distributions contingent on operational recovery and cash generation restoration.
Revenue contraction risk from continued demand deterioration in core printing media business, which declined 6.7% YoY and faces structural headwinds from digitalization trends and competitive intensity. The segment represents 94.9% of total revenue, making company performance highly sensitive to this market's trajectory. Quantified impact: 1 percentage point sustained revenue decline reduces operating profit by approximately 0.8B yen at current margin structure.
Working capital efficiency deterioration risk with DSO of 84 days and DIO of 125 days producing CCC of 191 days, substantially elevated versus typical manufacturing benchmarks of 60-90 days CCC. Inventory increased 3.4B yen YoY while accounts payable decreased 1.4B yen (-30.1%), consuming 7.6B yen of operating cash flow. Quantified impact: 10-day CCC improvement would release approximately 2.3B yen cash.
Leverage covenant risk with Debt/EBITDA of 4.39x exceeding typical bank covenant thresholds of 3.0-3.5x, despite absolute debt level remaining moderate at 19.2B yen long-term loans. Operating loss position eliminates interest coverage capacity (calculated -7.1x), though absolute interest expense of 0.3B yen remains manageable. Return to operating profitability required to restore covenant compliance and maintain credit facility access.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the printing consumables and plastic molding manufacturing sector. Based on financial characteristics, the core business faces margin pressure typical of mature B2B consumables markets experiencing digital substitution.
Profitability: Operating margin -2.7% (company currently below industry profitability due to restructuring cycle; industry median for printing consumables manufacturers typically ranges 3-8%). ROE -33.6% reflects current-period loss versus industry median of 5-10% for established manufacturers.
Financial Health: Equity ratio 57.4% (company maintains stronger balance sheet position versus industry median of 40-50% for capital-intensive manufacturers). Debt-to-equity 0.24x (conservative leverage versus industry median of 0.5-0.8x). However, Debt/EBITDA of 4.39x exceeds prudent leverage levels of 2.0-3.0x typical for stable manufacturers.
Efficiency: Operating margin deficit relative to industry reflects both cyclical operational challenges and structural cost base requiring adjustment. Working capital efficiency with CCC of 191 days substantially exceeds typical manufacturing benchmarks of 90-120 days, indicating inventory management and receivables collection warrant improvement to approach industry standards.
The company's balance sheet strength provides resilience during restructuring, though operating performance restoration toward industry-typical margins of mid-single digits remains the strategic priority.
FY2025 results characterized by extraordinary impairment charges of 24.8B yen (29.2% of revenue) represent a major asset revaluation and restructuring event rather than operating collapse, with underlying operating loss of -2.3B yen indicating operational challenges requiring turnaround execution. The magnitude of impairment suggests management addressed legacy asset overvaluation, potentially clearing balance sheet for future recovery.
Working capital deterioration with CCC expanding to 191 days and operating cash flow compressed to 1.0B yen despite revenue scale of 84.8B yen highlights cash conversion efficiency as critical operational focus area. Inventory increase of 3.4B yen and accounts payable reduction of 1.4B yen consumed 7.6B yen operating cash, indicating procurement and demand planning optimization represent measurable improvement opportunities.
Balance sheet resilience demonstrated through equity ratio maintenance at 57.4% and liquidity coverage with current ratio of 268.0% provides financial capacity to execute operational turnaround, though Debt/EBITDA elevation to 4.39x and FCF deficit of -4.3B yen require near-term profitability restoration to avoid covenant pressure and liquidity consumption. Dividend maintenance at 78 yen sourced from capital surplus rather than earnings signals management confidence in recovery trajectory while acknowledging current-period earnings insufficiency.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
Ordinary loss of -1.6B yen versus operating loss of -2.3B yen shows non-operating net contribution of approximately 0.7B yen, comprising primarily dividend income of 0.6B yen and FX gains of 0.3B yen against interest expense of 0.3B yen. Non-operating income represents 1.3% of revenue with stable dividend income and favorable currency effects providing modest support. However, the gap between ordinary loss and net loss exceeds 25B yen due to extraordinary items, with impairment losses of 24.8B yen representing 29.2% of revenue and constituting a material non-recurring charge. Operating CF of 1.0B yen severely underperformed relative to operating loss magnitude, as working capital deterioration absorbed 7.6B yen (inventory build of 3.4B yen and payables reduction of 4.9B yen). The OCF/EBITDA ratio of 0.23x indicates only 23% of EBITDA converted to cash, signaling accruals build-up and earnings quality concerns even adjusting for extraordinary items. The combination of negative operating margins, substantial non-cash impairment charges, and weak cash conversion indicates low recurring earnings quality requiring operational restructuring to restore sustainable profitability and cash generation.
Progress rate versus full-year guidance shows revenue achievement of 94.2% (84.8B yen actual vs 90.0B yen forecast), operating loss versus operating income forecast of 1.5B yen, ordinary loss versus ordinary income forecast of 1.2B yen, indicating substantial shortfall against initial expectations. The company maintained full-year guidance of revenue 90.0B yen (+6.2% YoY), operating income 1.5B yen (recovery to profitability), ordinary income 1.2B yen, and EPS forecast of 359.32 yen despite full-year results already reported, suggesting these figures represent preliminary outlook rather than achieved results requiring clarification. Actual FY2025 results fell significantly short of internal targets, with operating loss of -2.3B yen versus +1.5B yen forecast (-3.8B yen shortfall) and net loss of -26.7B yen versus implied profit, primarily due to unforecasted impairment charges of 24.8B yen. The revenue shortfall of 5.2B yen (-5.8%) indicates demand challenges exceeded management expectations, while the absence of revised guidance suggests potential reporting timing interpretation issues or preliminary next-period framework presentation.
Annual dividend of 78 yen per share maintained despite net loss of -26.7B yen. The reported payout ratio of 30.0% appears calculated on a normalized or target basis rather than actual earnings, as dividend payment of 1.4B yen against net loss produces mathematically negative conventional payout ratio. Dividend payment consumes -5.2% of net income (negative earnings basis) or represents total shareholder payout from capital reserves given the loss position. Total return ratio considering dividends of 1.4B yen and negligible share buybacks against negative net income indicates dividends funded entirely from retained earnings or capital surplus rather than current period earnings. The dividend note specifies that the FY2025 year-end dividend is entirely sourced from capital surplus rather than retained earnings, confirming non-earnings-based distribution. FCF of -4.3B yen indicates dividend payment not supported by free cash flow, requiring balance sheet liquidity drawdown. The dividend policy for FY2026 remains undetermined per management disclosure, suggesting future distributions contingent on operational recovery and cash generation restoration.
Revenue contraction risk from continued demand deterioration in core printing media business, which declined 6.7% YoY and faces structural headwinds from digitalization trends and competitive intensity. The segment represents 94.9% of total revenue, making company performance highly sensitive to this market's trajectory. Quantified impact: 1 percentage point sustained revenue decline reduces operating profit by approximately 0.8B yen at current margin structure.
Working capital efficiency deterioration risk with DSO of 84 days and DIO of 125 days producing CCC of 191 days, substantially elevated versus typical manufacturing benchmarks of 60-90 days CCC. Inventory increased 3.4B yen YoY while accounts payable decreased 1.4B yen (-30.1%), consuming 7.6B yen of operating cash flow. Quantified impact: 10-day CCC improvement would release approximately 2.3B yen cash.
Leverage covenant risk with Debt/EBITDA of 4.39x exceeding typical bank covenant thresholds of 3.0-3.5x, despite absolute debt level remaining moderate at 19.2B yen long-term loans. Operating loss position eliminates interest coverage capacity (calculated -7.1x), though absolute interest expense of 0.3B yen remains manageable. Return to operating profitability required to restore covenant compliance and maintain credit facility access.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the printing consumables and plastic molding manufacturing sector. Based on financial characteristics, the core business faces margin pressure typical of mature B2B consumables markets experiencing digital substitution.
Profitability: Operating margin -2.7% (company currently below industry profitability due to restructuring cycle; industry median for printing consumables manufacturers typically ranges 3-8%). ROE -33.6% reflects current-period loss versus industry median of 5-10% for established manufacturers.
Financial Health: Equity ratio 57.4% (company maintains stronger balance sheet position versus industry median of 40-50% for capital-intensive manufacturers). Debt-to-equity 0.24x (conservative leverage versus industry median of 0.5-0.8x). However, Debt/EBITDA of 4.39x exceeds prudent leverage levels of 2.0-3.0x typical for stable manufacturers.
Efficiency: Operating margin deficit relative to industry reflects both cyclical operational challenges and structural cost base requiring adjustment. Working capital efficiency with CCC of 191 days substantially exceeds typical manufacturing benchmarks of 90-120 days, indicating inventory management and receivables collection warrant improvement to approach industry standards.
The company's balance sheet strength provides resilience during restructuring, though operating performance restoration toward industry-typical margins of mid-single digits remains the strategic priority.
FY2025 results characterized by extraordinary impairment charges of 24.8B yen (29.2% of revenue) represent a major asset revaluation and restructuring event rather than operating collapse, with underlying operating loss of -2.3B yen indicating operational challenges requiring turnaround execution. The magnitude of impairment suggests management addressed legacy asset overvaluation, potentially clearing balance sheet for future recovery.
Working capital deterioration with CCC expanding to 191 days and operating cash flow compressed to 1.0B yen despite revenue scale of 84.8B yen highlights cash conversion efficiency as critical operational focus area. Inventory increase of 3.4B yen and accounts payable reduction of 1.4B yen consumed 7.6B yen operating cash, indicating procurement and demand planning optimization represent measurable improvement opportunities.
Balance sheet resilience demonstrated through equity ratio maintenance at 57.4% and liquidity coverage with current ratio of 268.0% provides financial capacity to execute operational turnaround, though Debt/EBITDA elevation to 4.39x and FCF deficit of -4.3B yen require near-term profitability restoration to avoid covenant pressure and liquidity consumption. Dividend maintenance at 78 yen sourced from capital surplus rather than earnings signals management confidence in recovery trajectory while acknowledging current-period earnings insufficiency.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.